United States Diabetes Drugs Market Report 2016

October 2016 | 120 pages | ID: U99161897FDEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Diabetes Drugs

Revenue, means the sales value of Diabetes Drugs

This report studies sales (consumption) of Diabetes Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Lantus
• NovoLog
• Humalog
• Levemir
• Actos

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Human insulins and analogues
• Alpha-glucosidase inhibitors
• Biguanides
• DPP-4 inhibitors
• Meglitinides
• Sulphonylureas
• Thiazolidinediones

Split by applications, this report focuses on sales, market share and growth rate of Diabetes Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Diabetes Drugs Market Report 2016

1 DIABETES DRUGS OVERVIEW

1.1 Product Overview and Scope of Diabetes Drugs
1.2 Classification of Diabetes Drugs
  1.2.1 Human insulins and analogues
  1.2.2 Alpha-glucosidase inhibitors
  1.2.3 Biguanides
  1.2.4 DPP-4 inhibitors
  1.2.5 Meglitinides
  1.2.6 Sulphonylureas
  1.2.7 Thiazolidinediones
1.3 Application of Diabetes Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Diabetes Drugs (2011-2021)
  1.4.1 United States Diabetes Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Diabetes Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES DIABETES DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Diabetes Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Diabetes Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Diabetes Drugs Average Price by Manufactures (2015 and 2016)
2.4 Diabetes Drugs Market Competitive Situation and Trends
  2.4.1 Diabetes Drugs Market Concentration Rate
  2.4.2 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DIABETES DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Diabetes Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Diabetes Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Diabetes Drugs Price by Type (2011-2016)
3.4 United States Diabetes Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DIABETES DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Diabetes Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Diabetes Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DIABETES DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Lantus
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Diabetes Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Lantus Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 NovoLog
  5.2.2 Diabetes Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 NovoLog Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Humalog
  5.3.2 Diabetes Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Humalog Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Levemir
  5.4.2 Diabetes Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Levemir Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Actos
  5.5.2 Diabetes Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Actos Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview

6 DIABETES DRUGS MANUFACTURING COST ANALYSIS

6.1 Diabetes Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Diabetes Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Diabetes Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DIABETES DRUGS MARKET FORECAST (2016-2021)

10.1 United States Diabetes Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Diabetes Drugs Sales Forecast by Type (2016-2021)
10.3 United States Diabetes Drugs Sales Forecast by Application (2016-2021)
10.4 Diabetes Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Diabetes Drugs
Table Classification of Diabetes Drugs
Figure United States Sales Market Share of Diabetes Drugs by Type in 2015
Figure Human insulins and analogues Picture
Figure Alpha-glucosidase inhibitors Picture
Figure Biguanides Picture
Figure DPP-4 inhibitors Picture
Figure Meglitinides Picture
Figure Sulphonylureas Picture
Figure Thiazolidinediones Picture
Table Application of Diabetes Drugs
Figure United States Sales Market Share of Diabetes Drugs by Application in 2015
Figure United States Diabetes Drugs Sales and Growth Rate (2011-2021)
Figure United States Diabetes Drugs Revenue and Growth Rate (2011-2021)
Table United States Diabetes Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Diabetes Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Diabetes Drugs Sales Share by Manufacturers
Figure 2016 Diabetes Drugs Sales Share by Manufacturers
Table United States Diabetes Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Diabetes Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Diabetes Drugs Revenue Share by Manufacturers
Table 2016 United States Diabetes Drugs Revenue Share by Manufacturers
Table United States Market Diabetes Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Diabetes Drugs Average Price of Key Manufacturers in 2015
Figure Diabetes Drugs Market Share of Top 3 Manufacturers
Figure Diabetes Drugs Market Share of Top 5 Manufacturers
Table United States Diabetes Drugs Sales by Type (2011-2016)
Table United States Diabetes Drugs Sales Share by Type (2011-2016)
Figure United States Diabetes Drugs Sales Market Share by Type in 2015
Table United States Diabetes Drugs Revenue and Market Share by Type (2011-2016)
Table United States Diabetes Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Diabetes Drugs by Type (2011-2016)
Table United States Diabetes Drugs Price by Type (2011-2016)
Figure United States Diabetes Drugs Sales Growth Rate by Type (2011-2016)
Table United States Diabetes Drugs Sales by Application (2011-2016)
Table United States Diabetes Drugs Sales Market Share by Application (2011-2016)
Figure United States Diabetes Drugs Sales Market Share by Application in 2015
Table United States Diabetes Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Diabetes Drugs Sales Growth Rate by Application (2011-2016)
Table Lantus Basic Information List
Table Lantus Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lantus Diabetes Drugs Sales Market Share (2011-2016)
Table NovoLog Basic Information List
Table NovoLog Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NovoLog Diabetes Drugs Sales Market Share (2011-2016)
Table Humalog Basic Information List
Table Humalog Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Humalog Diabetes Drugs Sales Market Share (2011-2016)
Table Levemir Basic Information List
Table Levemir Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levemir Diabetes Drugs Sales Market Share (2011-2016)
Table Actos Basic Information List
Table Actos Diabetes Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actos Diabetes Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetes Drugs
Figure Manufacturing Process Analysis of Diabetes Drugs
Figure Diabetes Drugs Industrial Chain Analysis
Table Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2015
Table Major Buyers of Diabetes Drugs
Table Distributors/Traders List
Figure United States Diabetes Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Diabetes Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Diabetes Drugs Production Forecast by Type (2016-2021)
Table United States Diabetes Drugs Consumption Forecast by Application (2016-2021)